| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.9 |
| Renal Disease |
0 |
0.67 |
| Kidney |
0 |
0.64 |
| Preventive Screening |
0 |
0.5 |
| End-Stage Renal Disease |
0 |
0.46 |
| Heart Failure (HF) |
0 |
0.41 |
| Hypertension |
0 |
0.4 |
| Blood Chemistry |
0 |
0.39 |
| Hemodialysis |
0 |
0.38 |
| Renal Cell Carcinoma |
0 |
0.33 |
| Type 1 Diabetes Mellitus |
0 |
0.32 |
| Type 2 Diabetes Mellitus |
0 |
0.32 |
| SGLT2 Inhibitor |
0 |
0.29 |
| Cardiovascular Risk Management |
0 |
0.21 |
| Heart |
0 |
0.21 |
| Myocardial Infarction (MI) |
0 |
0.16 |
| Clinical Guidelines |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Dialysis |
0 |
0.14 |
| Primary Care |
0 |
0.14 |
| Cancer |
0 |
0.11 |
| Health Policy |
0 |
0.11 |
| Metabolism |
0 |
0.11 |
| Receptors |
0 |
0.11 |
| Transplantation |
0 |
0.11 |
| Breast Cancer |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.07 |
| Colonoscopy |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Electronic Health Record (EHR) |
0 |
0.07 |
| Electronic Medical Record |
0 |
0.07 |
| Lung Cancer |
0 |
0.07 |
| Metabolic Syndrome |
0 |
0.07 |